Join us on Saturday, March 20th, 2021, at 12:00 pm ET for a webinar featuring a discussion around the latest in emerging stem-cell therapies for retinal degenerative diseases, including therapies in, or moving toward, clinical trials.
The Foundation’s best-in-class genetic testing program enables any eye care professional in the US to order no-cost genetic testing through the Foundation’s My Retina Tracker Program and genetic counseling for patients clinically diagnosed with an IRD.
The partnership includes genetic testing provided by Blueprint Genetics, which utilizes a state-of-the-art genetic testing panel for IRDs, and genetic counseling from InformedDNA, which are experts in helping patients understand what the test results mean for them and their families.
Also, patients can upload information about their condition to the My Retina Tracker Registry to get on the radar screen of researchers and therapy developers around the world, including those recruiting for clinical trials for emerging therapies.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.